Why alternative medicine still tests veterinary science

A new SkeptVet essay, “Is Alternative Medicine Compatible with Science?”, reopens one of veterinary medicine’s most persistent fault lines: whether “alternative” therapies can coexist with science-based care, or whether the term itself signals a lower evidentiary bar. The article’s core argument is direct: if a therapy is shown to be safe and effective, it becomes medicine, not “alternative medicine,” and clinicians shouldn’t relax their standards just because a product or practice is marketed as natural, holistic, or integrative. (skeptvet.com)

That framing arrives at a moment when organized veterinary medicine is still sorting out how to talk about integrative care. In early 2025, AVMA delegates approved a revised policy on complementary, alternative, and integrative veterinary medicine that, according to meeting summaries, emphasizes that integrative modalities should be held to the same standards as traditional therapies. At the same time, the broader marketplace for these services continues to grow through CE programs, certifications, and practice marketing, even as the evidence base remains uneven across modalities. (members.nafv.org)

SkeptVet places that tension front and center. The article argues that what unites many complementary and alternative veterinary medicine approaches is not a coherent scientific framework, but their positioning as something outside mainstream, evidence-based medicine. It specifically criticizes the use of terms like “natural” and “traditional” as proxies for safety or efficacy, and points to examples where veterinarians might reject weak evidence for a pharmaceutical product while accepting similarly weak or weaker evidence for an herbal or homeopathic intervention. (skeptvet.com)

That critique lines up with positions from more mainstream reference bodies, though often in less confrontational language. The Merck Veterinary Manual says treatment recommendations should be based on “science and substance,” and that pet parents should have factual information about benefits and risks when considering integrative options. The BSAVA likewise warns that regulation is meant to protect safety and does not itself prove a treatment works, while reserving the term “integrative medicine” for combinations of conventional care with complementary therapies supported by reasonable evidence of safety and effectiveness. (merckvetmanual.com)

The sharpest industry pushback has come from evidence-based medicine advocates. In a 2025 letter opposing recognition of veterinary acupuncture as an AVMA specialty, the Evidence-Based Veterinary Medical Association argued that acupuncture lacks a consistent evidence base and that the strongest controlled trials and reviews have not shown effects beyond placebo for any medical condition in humans or animals. That position is not universal across the profession, but it shows how high the stakes have become as some integrative modalities move from the margins toward formal recognition, credentialing, and expanded CE visibility. (skeptvet.com)

Why it matters: For practicing veterinarians, technicians, and hospital leaders, this debate has concrete implications. It affects how clinics counsel pet parents, what claims they make in marketing, how they document informed consent, and whether they risk delaying proven treatment while trialing lower-evidence interventions. It also touches professional identity: evidence-based veterinary medicine has long been framed as the integration of research evidence, clinical expertise, and client circumstances, not a rejection of individualized care. The real question for clinics isn’t whether a modality is branded integrative or alternative, but whether the underlying evidence, biologic plausibility, and risk-benefit profile justify offering it. (veterinaryevidence.org)

There’s also a misinformation angle. When therapies are presented as validated because they are longstanding, popular, lightly regulated, or taught in CE, pet parents may reasonably infer a stronger evidence base than actually exists. That can blur the line between supportive adjunctive care and unsupported claims. For veterinary teams already navigating online health misinformation, the challenge is to communicate uncertainty clearly without dismissing client values or the desire for less invasive options. (merckvetmanual.com)

What to watch: The next phase is likely to play out in policy language, specialty-recognition decisions, and the way veterinary organizations define “integrative” care. If more groups adopt the standard that any modality, conventional or not, must meet the same evidentiary threshold, the label may matter less, and the proof may matter more. (members.nafv.org)